Detalhe da pesquisa
1.
Surgical Management and Long-Term Outcomes of BIA-ALCL: A Multidisciplinary Approach.
Ann Surg Oncol;
31(3): 2032-2040, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38102324
2.
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.
Blood;
140(8): 851-860, 2022 08 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35679476
3.
Spotlight on polatuzumab vedotin: new standards for diffuse large B-cell lymphoma?
Haematologica;
2024 May 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38813707
4.
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study.
Haematologica;
109(1): 209-219, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37439343
5.
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomes.
Haematologica;
109(1): 200-208, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37646672
6.
Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis.
Haematologica;
2024 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38752279
7.
Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era.
Blood;
137(1): 39-48, 2021 01 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32730585
8.
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.
Blood;
138(26): 2828-2837, 2021 12 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34653242
9.
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study.
Haematologica;
108(3): 822-832, 2023 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36263843
10.
Central nervous system lymphomas-Assessment and treatment and prevention of central nervous system relapse.
Hematol Oncol;
2023 Jun 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37381737
11.
Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study.
Cancer;
128(8): 1595-1604, 2022 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35157306
12.
Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma.
Haematologica;
107(5): 1131-1143, 2022 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34162177
13.
An Updated Approach and Understanding of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
J Natl Compr Canc Netw;
20(3): 309-315, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35276670
14.
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw;
20(3): 285-308, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35276674
15.
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study.
Haematologica;
105(6): 1604-1612, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31537689
16.
ASO Author Reflections: Approaching BIA-ACL Diagnosis and Treatment.
Ann Surg Oncol;
31(4): 2789-2790, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38324236
17.
Predictors of cardiovascular outcome and rehospitalization in elderly patients with heart failure.
Eur J Clin Invest;
49(2): e13044, 2019 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30368802
18.
Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes.
J Eur Acad Dermatol Venereol;
2024 May 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38818876
19.
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
Biol Blood Marrow Transplant;
24(9): 1814-1822, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29857196
20.
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas.
Blood;
127(7): 858-68, 2016 Feb 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26603836